Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Syndax Pharmaceuticals Inc (DE:1T3)
MUNICH:1T3
RESEARCH TOOLSreports
Syndax Pharmaceuticals (1T3) Stock Forecast & Price Target
1 Followers
See the Price Targets and Ratings of:
1T3 Analyst Ratings
Strong Buy
9 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
1T3 Stock 12 Month Forecast
Average Price Target
€31.37
▲(61.69% Upside)
| Highest Price Target€42.21 | Average Price Target€31.37 | Lowest Price Target€21.57 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
04/26/24
Bank of America Securities
Assigned
04/09/24
Goldman Sachs
Reiterated
03/05/24
Mizuho Securities
Initiated
02/09/24
Stifel Nicolaus
€34.71
Buy
78.90%
Upside
Reiterated
01/03/24
Wall Street Analysts Are Bullish on Top Healthcare Picks
Guggenheim
€40.34
Buy
107.92%
Upside
Reiterated
10/03/23
Syndax price target raised to $43 from $42 at GuggenheimSyndax price target raised to $43 from $42 at Guggenheim
B.Riley Financial
€33.77
Buy
74.07%
Upside
Reiterated
08/04/23
Thursday, 8/3, Syndax (SNDX) reported 2Q earnings and provided a business update. Syndax remains a high conviction/Buy-rated late-stage, near-commercialization story with a plethora of catalysts remaining over the next ~12 months. Near term, we anticipate data from the KMT2Ar acute leukemias in 3Q to serve as a positive event for the shares.
Best Analysts Covering Syndax Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy DE:1T3 and Sell After:
1 Month
3 Months
1 Year
Success Rate
8/9 ratings generated profit
Average Return
+15.56%
reiterated a buy rating 2 months ago
Copying Justin Zelin's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +15.56% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
1T3 Analyst Recommendation Trends
Rating
Dec 23
Jan 24
Feb 24
Mar 24
Apr 24
Strong Buy
27
20
14
8
5
Buy
3
4
9
10
11
Hold
0
2
3
4
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
26
26
22
18
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
1T3 Financial Forecast
1T3 Stock Forecast FAQ
What is DE:1T3’s average 12-month price target, according to analysts?
Based on analyst ratings, Syndax Pharmaceuticals Inc’s 12-month average price target is €31.37.
What is DE:1T3’s upside potential, based on the analysts’ average price target?
Syndax Pharmaceuticals Inc has 61.69% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Syndax Pharmaceuticals Inc a Buy, Sell or Hold?
Syndax Pharmaceuticals Inc has a conensus rating of Strong Buy, which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.
What is Syndax Pharmaceuticals Inc’s share price target?
The average share price target for Syndax Pharmaceuticals Inc is €31.37. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €42.21 ,and the lowest forecast is €21.57. The average share price target represents 61.69% Increase from the current price of €19.4.
The highest analyst share price target is €42.21 ,and the lowest forecast is €21.57. The average share price target represents 61.69% Increase from the current price of €19.4.
What do analysts say about Syndax Pharmaceuticals Inc?
Syndax Pharmaceuticals Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of Syndax Pharmaceuticals Inc?
To buy shares of DE:1T3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.